Cargando…
Diversity and inclusion in clinical trials: Evolution throughout the development of an mRNA COVID-19 vaccine
Despite the importance of equitable representation in clinical trials, disparities persist with racial and ethnic minorities remaining largely underrepresented in trial populations. During the coronavirus disease 2019 (COVID-19) pandemic, wherein disease disproportionately affected racial and ethnic...
Autores principales: | Hill, Jameka, Montross, Diane, Ivarsson, Melanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169614/ https://www.ncbi.nlm.nih.gov/pubmed/37181705 http://dx.doi.org/10.3389/fpubh.2023.1113003 |
Ejemplares similares
-
From lab to mass production: a policy for enabling the licensing of mRNA vaccines
por: Panagopoulos, Andreas, et al.
Publicado: (2023) -
A novel COVID-19 program, delivering vaccines throughout rural and remote Australia
por: Gardiner, Fergus W., et al.
Publicado: (2023) -
The Safety and Effectiveness of mRNA Vaccines Against SARS-CoV-2
por: Jamous, Yahya F, et al.
Publicado: (2023) -
Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review
por: Lui, David Tak Wai, et al.
Publicado: (2021) -
Systematic review of spontaneous reports of myocarditis and pericarditis in transplant recipients and immunocompromised patients following COVID-19 mRNA vaccination
por: Lane, Samantha, et al.
Publicado: (2022)